Keros Therapeutics (KROS) Shareholder's Equity Growth (1y) (2020 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Keros Therapeutics | 403.85 Mn | 116.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -46.96% |
| Sep 30, 2025 | 32.04% |
| Jun 30, 2025 | 67.90% |
| Mar 31, 2025 | 60.56% |
| Dec 31, 2024 | 72.04% |
| Sep 30, 2024 | 80.11% |
| Jun 30, 2024 | 29.01% |
| Mar 31, 2024 | 27.88% |
| Dec 31, 2023 | 19.75% |
| Sep 30, 2023 | 22.74% |
| Jun 30, 2023 | 54.47% |
| Mar 31, 2023 | 58.83% |
| Dec 31, 2022 | 14.08% |
| Sep 30, 2022 | 10.32% |
| Jun 30, 2022 | -10.37% |
| Mar 31, 2022 | -10.02% |
| Dec 31, 2021 | -7.09% |
| Sep 30, 2021 | 67.09% |
| Jun 30, 2021 | 66.71% |
| Mar 31, 2021 | 1,098.80% |
| Dec 31, 2020 | 1,445.89% |
| Sep 30, 2020 | 882.19% |
| Jun 30, 2020 | 1,171.57% |
| Mar 31, 2020 | -140.14% |